Literature DB >> 20116682

The 2009 proposed rule for prospective ESRD payment: historical perspectives and public policies--bundle up!

Daniel E Weiner, Suzanne G Watnick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20116682     DOI： 10.1053/j.ajkd.2009.12.005

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  6 in total

1.  Home Dialysis in the Prospective Payment System Era.

Authors:  Eugene Lin; Xingxing S Cheng; Kuo-Kai Chin; Talhah Zubair; Glenn M Chertow; Eran Bendavid; Jayanta Bhattacharya
Journal:  J Am Soc Nephrol       Date:  2017-05-10       Impact factor: 10.121

Review 2.  A review of the costs and cost effectiveness of interventions in chronic kidney disease: implications for policy.

Authors:  Joseph Menzin; Lisa M Lines; Daniel E Weiner; Peter J Neumann; Christine Nichols; Lauren Rodriguez; Irene Agodoa; Tracy Mayne
Journal:  Pharmacoeconomics       Date:  2011-10       Impact factor: 4.981

3.  Nadir hemoglobin levels after discontinuation of epoetin in hemodialysis patients.

Authors:  Jose A Calvo; Dana C Miskulin; Klemens B Meyer; Daniel E Weiner
Journal:  Clin J Am Soc Nephrol       Date:  2010-07-22       Impact factor: 8.237

4.  Heart failure severity scoring system and medical- and health-related quality-of-life outcomes: the HEMO study.

Authors:  Kelly V Liang; Francis Pike; Christos Argyropoulos; Lisa Weissfeld; Jeffrey Teuteberg; Mary Amanda Dew; Mark L Unruh
Journal:  Am J Kidney Dis       Date:  2011-05-06       Impact factor: 8.860

5.  ESKD Treatment Choices Model: Responsible Home Dialysis Growth Requires Systems Changes.

Authors:  Eric L Wallace; Michael Allon
Journal:  Kidney360       Date:  2020-03-27

6.  Variability in Cinacalcet Prescription across US Hemodialysis Facilities.

Authors:  Douglas S Fuller; Shan Xing; Vasily Belozeroff; Alon Yehoshua; Hal Morgenstern; Bruce M Robinson; Robert J Rubin; Nisha Bhatt; Ronald L Pisoni
Journal:  Clin J Am Soc Nephrol       Date:  2019-01-21       Impact factor: 8.237
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.